22nd December 2018 September 20-21, 2019 The meeting is focused on therapy of the liver disease in α1-antitrypsin deficiency (AATD) and is addressed to clinicians and basic science researchers. The conference will provide a comprehensive overview and detailed lectures on cutting-edge translational and clinical research and will foster the exchange ofContinue Reading

  On Monday 17th December we went to see Mereo BioPharma at their office in London. Mereo BioPharma have recently started dosing in their Phase 2 clinical trial for MPH-966 (alvelestat). The study will recruit in America, Canada, Europe and the UK. The plan is that people who are PiZZContinue Reading